NYSEAMERICAN:SENS - Senseonics Stock Price, Forecast & News

Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."

Senseonics Holdings Inc (NYSEAMERICAN:SENS) posted its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.16) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.16). The business had revenue of $4.32 million for the quarter, compared to analyst estimates of $6.18 million. View Senseonics' Earnings History.

Senseonics is scheduled to release their next quarterly earnings announcement on Tuesday, March 10th 2020. View Earnings Estimates for Senseonics.

Senseonics issued an update on its FY 2019 After-Hours earnings guidance on Monday, November, 25th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $$20-22 million, compared to the consensus revenue estimate of $$26.62 million.

6 equities research analysts have issued twelve-month price targets for Senseonics' stock. Their forecasts range from $1.00 to $2.50. On average, they anticipate Senseonics' share price to reach $1.90 in the next year. This suggests a possible upside of 121.0% from the stock's current price. View Analyst Price Targets for Senseonics.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Senseonics.

Media coverage about SENS stock has been trending extremely negative recently, according to InfoTrie Sentiment. The research group ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Senseonics earned a media sentiment score of -5.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Senseonics.

Some companies that are related to Senseonics include Volpara Health Tech (VHT), Akumin (AKU), Exagen (XGN), Renalytix Ai (RENX), Profound Medical (PRN), Palatin Technologies (PTN), Oncosil Medical (OSL), MaxCyte (MXCT), Yourgene Health (YGEN), Lexagene (LXG), BARD1 Life Sciences (BD1), Sernova (SVA), GeneNews (GEN), Oncimmune (ONC) and SQI Diagnostics (SQD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include VirnetX (VHC), CytoDyn (CYDY), Tandem Diabetes Care (TNDM), TransEnterix (TRXC), Novavax (NVAX), Sorrento Therapeutics (SRNE), Tetraphase Pharmaceuticals (TTPH), Advanced Micro Devices (AMD), Rigel Pharmaceuticals (RIGL) and TherapeuticsMD (TXMD).

Senseonics' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Trust Co. of Oklahoma (0.02%). Company insiders that own Senseonics stock include Douglas A Roeder, Mukul Jain and Timothy T Goodnow. View Institutional Ownership Trends for Senseonics.

SENS stock was acquired by a variety of institutional investors in the last quarter, including Trust Co. of Oklahoma. View Insider Buying and Selling for Senseonics.

Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SENS stock can currently be purchased for approximately $0.86.

Senseonics has a market capitalization of $174.95 million. Senseonics employs 192 workers across the globe.View Additional Information About Senseonics.

The official website for Senseonics is http://www.senseonics.com/.

Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company can be reached via phone at +1-301-5157260.